On treating RPMI8226 human MM cells with equal total protein amounts of MBP-PTR1 fractions after each purification step, the specific activity of NF-κB response normalized to Oct-1 binding increased (Fig 1B and C). The gene discussed is NFKB1; the disease is Miyoshi myopathy.